Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

A boy on a ketogenic diet and anti-epileptic drugs developed skin issues due to stopping vitamin supplements, which improved with proper supplementation.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

PLD is an effective and safer alternative for treating breast cancer.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.